Follow us on




Q of the week

Q: Do clinical trials ever go wrong?

Get the Answer: 

Prototype devices

It is recognized that a manufacturer may wish to submit a small number  of "prototype models" of a device to clinical investigation in order to assess safety and/or performance; and those such prototypes may need to undergo a number of changes prior to large-scale production.

GCP-Focus
Dear Colleagues,
 
For Authors
 
GCP focus welcomes articles from Clinical Research Professionals from Hospitals, Industry and Academia.
 
Most articles in the GCP focus are about the methods and process of clinical research. We generally do not publish articles on the therapeutic results of clinical trials. Your article should offer practical advice for Clinical Research or Good Clinical Practices.
 
We have no hard-and-fast rules about article length. All articles must be strictly non-promotional in content. They should not have been published elsewhere, or have been submitted concurrently to any other journal or website.
 
If you have already written your article, please send it in. We will work with you to make the article outstanding. There is no specific deadline for submissions. There are no issue themes. Articles are typically published after receipt. Timing depends on the editorial process, other articles ready for publication, and composition of each issue.
 
The GCP HelpDesk neither pays for articles nor charges authors for publication.
 
 
GCPfocus Editorial Board
 
We are inviting our subscribers to become Editorial Board Members of the GCP focus, to be involved in its further development including improvement of content, contributing articles.
 
We now have number of  advisors/members from different regions of the world with about half representing the industry. The other half represents the academia/hospital sites.The criteria to become an Advisory/Editorial Board Member is that you have an interest in clinical trial matters - regulatory, ethical, design, medical writing, quality assurance, administration, management or trial conduct.
 
As a member you can contribute as much as you wish, and you may leave the Advisory/Editorial Board at any time.
 
If you wish to become an Advisory/Editorial Board member, please send a message to This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
 
We look forward for your contribution.
 
Editor-in-Chief, GCP focus

 

 
 
There are no events at this time

Links